Acadia Pharmaceuticals up Nearly 11%, on Track for Largest Percent Increase Since May 2025

Dow Jones06-27

ACADIA Pharmaceuticals Inc. $(ACAD)$ is currently at $26.30, up $2.59 or 10.9%

 

--Would be highest close since Jan. 26, 2026, when it closed at $26.86

--On pace for largest percent increase since May 16, 2025, when it rose 26.48%

--Currently up eight of the past nine days

--Currently up seven consecutive days; up 25.62% over this period

--Longest winning streak since Oct. 27, 2025, when it rose for seven straight trading days

--Best seven day stretch since the seven days ending May 27, 2025, when it rose 26.08%

--Up 21.67% this week; best weekly performance since the week ending May 16, 2025, when it rose 27.64%

--Up 21.45% month-to-date

--Down 1.52% year-to-date

--Down 53.85% from its all-time closing high of $57.00 on July 7, 2020

--Up 18.92% from 52 weeks ago (June 27, 2025), when it closed at $22.12

--Down 6.25% from its 52-week closing high of $28.06 on Dec. 22, 2025

--Up 31.13% from its 52-week closing low of $20.06 on Oct. 13, 2025

--Traded as high as $27.31; highest intraday level since Jan. 23, 2026, when it hit $27.81

--Up 15.13% at today's intraday high; largest intraday percent increase since May 16, 2025, when it rose as much as 43.35%

 

All data as of 12:30:38 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

June 26, 2026 12:34 ET (16:34 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment